The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions
Authors
Keywords
Everolimus, Sirolimus, mTOR Inhibitor, Tuberous Sclerosis Complex, Vigabatrin
Journal
DRUGS
Volume 76, Issue 5, Pages 551-565
Publisher
Springer Nature
Online
2016-02-29
DOI
10.1007/s40265-016-0552-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Everolimus for subependymal giant cell astrocytoma: 5-year final analysis
- (2015) David N. Franz et al. ANNALS OF NEUROLOGY
- Neurological and neuropsychiatric aspects of tuberous sclerosis complex
- (2015) Paolo Curatolo et al. LANCET NEUROLOGY
- Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial
- (2015) John J. Bissler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- mTOR Inhibitors in Tuberous Sclerosis Complex
- (2015) Paolo Curatolo et al. Current Neuropharmacology
- Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2
- (2014) H. S. Rugo et al. ANNALS OF ONCOLOGY
- EEG abnormalities preceding the epilepsy onset in tuberous sclerosis complex patients – A prospective study of 5 patients
- (2014) D. Domańska-Pakieła et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study
- (2014) David Neal Franz et al. LANCET ONCOLOGY
- The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1
- (2014) J. C. Kingswood et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- TOSCA – first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex
- (2014) John C Kingswood et al. Orphanet Journal of Rare Diseases
- Strategies for the management of adverse events associated with mTOR inhibitors
- (2014) Bruce Kaplan et al. Transplantation Reviews
- Everolimus treatment of refractory epilepsy in tuberous sclerosis complex
- (2013) Darcy A. Krueger et al. ANNALS OF NEUROLOGY
- Predictors of seizure freedom after surgical management of tuberous sclerosis complex: A systematic review and meta-analysis
- (2013) Kai Zhang et al. EPILEPSY RESEARCH
- Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations
- (2013) Sergiusz Jóźwiak et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex
- (2013) Katarzyna Kotulska et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
- (2013) John J Bissler et al. LANCET
- Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma
- (2013) D. A. Krueger et al. NEUROLOGY
- Subependymal Giant Cell Astrocytoma: Diagnosis, Screening, and Treatment. Recommendations From the International Tuberous Sclerosis Complex Consensus Conference 2012
- (2013) Jonathan Roth et al. PEDIATRIC NEUROLOGY
- Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
- (2013) Darcy A. Krueger et al. PEDIATRIC NEUROLOGY
- Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
- (2013) Hope Northrup et al. PEDIATRIC NEUROLOGY
- Surgical Treatment of Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex Patients
- (2013) Katarzyna Kotulska et al. PEDIATRIC NEUROLOGY
- Vigabatrin Inhibits Seizures and mTOR Pathway Activation in a Mouse Model of Tuberous Sclerosis Complex
- (2013) Bo Zhang et al. PLoS One
- Management of epilepsy associated with tuberous sclerosis complex (TSC): Clinical recommendations
- (2012) Paolo Curatolo et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complex
- (2012) Sam Amin et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
- (2012) David Neal Franz et al. LANCET
- Low-Dose Oral Sirolimus and the Risk of Menstrual-Cycle Disturbances and Ovarian Cysts: Analysis of the Randomized Controlled SUISSE ADPKD Trial
- (2012) Matthias Braun et al. PLoS One
- The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective
- (2011) Romina Moavero et al. CHILDS NERVOUS SYSTEM
- Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial
- (2011) D. M. Davies et al. CLINICAL CANCER RESEARCH
- The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway
- (2011) Sharon S. McDaniel et al. EPILEPSIA
- Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis
- (2011) Raffaella Cusmai et al. EPILEPSY & BEHAVIOR
- Low glycemic index treatment for epilepsy in tuberous sclerosis complex
- (2011) Anna M. Larson et al. EPILEPSY RESEARCH
- Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex
- (2011) Sergiusz Jóźwiak et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex
- (2011) Marta Perek-Polnik et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis
- (2011) David Neal Franz Expert Review of Anticancer Therapy
- Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease
- (2011) Sandra L. Dabora et al. PLoS One
- Everolimus
- (2011) Monique P. Curran PEDIATRIC DRUGS
- Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses
- (2010) Geertrude H. Struijk et al. KIDNEY INTERNATIONAL
- Tuberous Sclerosis Complex Renal Disease
- (2010) Bradley P. Dixon et al. NEPHRON EXPERIMENTAL NEPHROLOGY
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis
- (2010) Darcy A. Krueger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vagus Nerve Stimulation for Refractory Epilepsy in Tuberous Sclerosis
- (2010) Nelia Zamponi et al. PEDIATRIC NEUROLOGY
- Vigabatrin: 2008 Update
- (2009) L. James Willmore et al. EPILEPSIA
- Refractory epilepsy in tuberous sclerosis: Vagus nerve stimulation with or without subsequent resective surgery
- (2009) Robert E. Elliott et al. EPILEPSY & BEHAVIOR
- Early control of seizures improves long-term outcome in children with tuberous sclerosis complex
- (2009) Roberta Bombardieri et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Tsc/mTORC1 signaling in oocytes governs the quiescence and activation of primordial follicles
- (2009) D. Adhikari et al. HUMAN MOLECULAR GENETICS
- Missense mutations to the TSC1 gene cause tuberous sclerosis complex
- (2008) Mark Nellist et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Tuberous sclerosis
- (2008) Paolo Curatolo et al. LANCET
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
- (2008) John J. Bissler et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started